HRH the Duke of Kent, President of King Edward VII’s Hospital, today officially re-opened the expanded outpatients unit at Emmanuel Kaye House in London. The Hospital’s newly refurbished unit has doubled in size and will now offer eleven consulting rooms to accompany the growing number of patients
New Assay Is First to Standardize to World Health Organization’s 5th International Standard for Chorionic Gonadotropin
Article • Trisomy 21
Down’s syndrome (also referred to as trisomy 21) is a genetic disorder caused by the presence of all or part of an extra copy of chromosome 21 in a person’s DNA.
Sanofi and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, today announce the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer.
Hedvig Hricak, Chair of the Radiology Department at the Memorial Sloan-Kettering Cancer Center, New York, USA, describes emerging applications and potential trends in gynaecological cancer treatment described at the 15th International Symposium Crossing Barriers
Modern imaging techniques greatly enhance the treatment selection
GE Healthcare yesterday announced the availability of the Giraffe® Stand-Alone Infant Resuscitation (STAR) System, which integrates critical capabilities to enhance effective resuscitation of newborns.
Accuvix A30 produces impressive results in the prenatal diagnostics arena and Samsung could become a serious contender in the ultrasound champions’ league.
Article • Ovarian viability
‘The egg timer test’ is widely used to help determine how long a woman can expect to remain fertile. Lately it has shown even greater potential for clinical use as a biomarker for ovarian viability.
Suspicion of venous thromboembolism (VTE) in a pregnant patient will quickly bring a radiologist to a choice, where the next step holds potentially significant consequences for both the mother and unborn child.
In 2012, Chicago’s Children’s Memorial Hospital will be in transition, with a change of name as well as location, when its top class technology, physicians, scientists, staff and patients transfer to a new state-of-the-art complex three miles away.
‘As we become more successful in the early detection and treatment of breast cancer, we tend to trivialise it. Yet one in 9 women still get breast cancer. Half of them become depressed, their partners don’t know how to react and their families are in disarray. We need to stop trivialising breast cancer. It kills women.’ So says Dr Fabienne Liebens, Head of the Saint-Pierre Hospital’s…
Prenatal ultrasound images are the first images we see of new humans. But the prenatal ultrasound first carried out by Professor Ian Donald in the late 50s has little to do with today’s potential with 3-D and 4-D imaging with Doppler and colour Doppler. The three tightly linked disciplines gynaecology, prenatal medicine and obstetrics would now be inconceivable without ultrasound
Catastrophes draw people closer, as demonstrated by the development of the new high-end ultrasound scanner Aplio 500 from Toshiba. The clinical evaluation period took place during the tsunami and the nuclear catastrophe in Fukusima. Professor Thomas Fischer at the Radiological Institute, Charité Clinic in Berlin, was impressed by the enormous commitment shown by the Japanese firm’s engineers…
Article • Artificial insemination
The birth, in France, of its first baby to be conceived by artificial insemination on top of the selection of an embryo based on its blood, has sent new flames into the hot parliamentary debate over the reform of bioethics law.
As one of the first in Europe, the FUS Centre at the Klinikum Dachau in Germany introduced MRgFUS in 2008 as a gentle alternative for the treatment of fibroids. The success that has since been achieved in this encouraged Dr Matthias Matzko, head of radiology and of the FUS Centre, to take on a leading role with the introduction to the market of the second product generation, the ExAblate One.…
Philips Electronics and Atom Medical Corporation, a major manufacturer of neonatal medical equipment, announced today that they are expanding their relationship to serve customers with a more complete portfolio of perinatal care solutions.
Ultrasound is the undisputed choice for foetal imaging. However, the lack of amniotic fluid, an unfavourable foetal position or maternal obesity could daunt even the best radiographer. In such circumstances prenatal magnetic resonance imaging (MRI) – a non-invasive and non-irradiating procedure – is a helpful diagnostic tool.
Current cervical cancer screening is time consuming and expensive, but now new breakthrough technology developed by European researchers should allow large-range screening by non-medical personnel with almost immediate results and at a much lower cost.
Data from the ATHENA (Addressing THE Need for Advanced HPV Diagnostics) USA registration trial, involving more than 47,000 women, demonstrate that two human papilloma virus genotypes, HPV 16 and HPV 18, can identify those women with cervical pre-cancer missed by cytologic examination with a Papanicolau (Pap) test.
A probe suitable for imaging soft tissue for use with the VivoSight Multi-Beam optical coherence tomography (OCT) imaging system has been launched by manufacturer Michelson Diagnostics. The probe enables in vivo imaging of oral and gynaecological tissue.
The latest analysis of a vaccine’s safety, efficacy and immunogenicity indicates that Cervarix, a human papilloma virus (HPV) vaccine offers sustained protection for over six years against infection by viral types HPV-16 and HPV-18, most commonly associated with cervical cancer.
Breast and cervical cancer together account for more than one quarter of all female cancer deaths worldwide, with the majority – including more than 85 % of all cervical cancer deaths – occurring in developing countries. However, a small number of highly effective programs demonstrate that much can be done to reduce risk and increase sustainable access to diagnosis and treatment for these…
A study presented at the annual meeting of the Radiological Society of North America (RSNA) revealed that MRI is a highly accurate means of identifying placenta accreta, a potentially life-threatening and increasingly common condition that is the leading cause of death for women just before and after giving birth.
The United Kingdom has a strong medical devices industry; more than 2,000 companies employ over 50,000 people and support the employment of many more in this field. About 200 of these medical manufacturers are at Medica this year, at various pavilions, including those representing Wales, Scotland and Northern Ireland. Among the UK exhibitors, Zilico Ltd is presenting, for the first time, a…